Telo Genomics is a Toronto diagnostics and genomics company built around proprietary 3-dimensional telomere analysis. Its website emphasizes TeloView®, a platform designed to measure genomic instability and generate prognostic or diagnostic insights. Current public materials highlight applications in smoldering multiple myeloma, measurable residual disease, Alzheimer’s disease, and prostate cancer.